When Benicar was first approved by the U.S. Food and Drug Administration for treating high blood pressure in 2002, it was hailed as a superior treatment option to existing drugs at the time.
In the years since, countless people have suffered from adverse and unexpected side effects while taking Benicar. These side effects include serious pregnancy-related risks like fetal toxicity and intestinal problems like sprue-like enteropathy.
Thousands have filed lawsuits against the makers of Benicar over claims that the companies failed to disclose risks. This resulted in Daiichi Sankyo and Forest Laboratories agreeing to a $300 million settlement if 95 percent of plaintiffs enrolled in the settlement program.